Joseph F Standing (J F Standing, Joseph Standing)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 44

Top Topics

Systematic Review

Respiratory Syncytial Virus

Top Venues

The Journal of antimicrobial chemotherapy

British journal of clinical pharmacology

Clinical pharmacology and therapeutics

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A Agyeman, Charles Miller, Mercy Okechukwu, Emily Kirkpatrick, Amy I Jacobs, Charlotte A Williams, Sunando Roy, Luz M Martin-Bernal, Rachel Williams, Claire Mary Smith, Theo Sanderson, Fiona B Ashford, Beena Emmanuel, Zaheer M Afzal, Adrian M Shields, Alex G Richter, Jienchi Dorward, Oghenekome Gbinigie, Oliver Van Hecke, Mark Lown, Nick Francis, Bhautesh Jani, Duncan B Richards, Najib M Rahman, Ly-Mee Yu, Nicholas P B Thomas, Nigel David Hart, Philip H Evans, Monique I Andersson, Gail Hayward, Kerenza Hood, Jonathan S Nguyen-Van-Tam, Paul Little, F D Richard Hobbs, Saye H Khoo, Christopher C Butler, David M Lowe, Judith Breuer, null null
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature communications 15 (1) (2024)
Qi Liu, Amita Joshi, Joseph F Standing, Piet H van der Graaf
Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine. Clinical pharmacology and therapeutics 115 (4) (2024)
Suzanne A M Wenker, Najla Alabdulkarim, John B Readman, Elise M A Slob, Giovanni Satta, Shanom Ali, Nishma Gadher, Rob Shulman, Joseph F Standing
Defining the pharmacokinetic/pharmacodynamic index of piperacillin/tazobactam within a hollow-fibre infection model to determine target attainment in intensive care patients. JAC-antimicrobial resistance 6 (2) (2024)
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A Agyeman, Charles Miller, Mercy Okechukwu, Emily Kirkpatrick, Amy I Jacobs, Charlotte A Williams, Sunando Roy, Luz M Martin-Bernal, Rachel Williams, Claire Mary Smith, Theo Sanderson, Fiona B Ashford, Beena Emmanuel, Zaheer M Afzal, Adrian M Shields, Alex G Richter, Jienchi Dorward, Oghenekome Gbinigie, Oliver Van Hecke, Mark Lown, Nick Francis, Bhautesh Jani, Duncan B Richards, Najib M Rahman, Ly-Mee Yu, Nicholas P B Thomas, Nigel David Hart, Philip H Evans, Monique I Andersson, Gail Hayward, Kerenza Hood, Jonathan S Nguyen-Van-Tam, Paul Little, F D Richard Hobbs, Saye H Khoo, Christopher C Butler, David M Lowe, Judith Breuer, null null
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature communications 15 (1) (2024)
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A Agyeman, Charles Miller, Mercy Okechukwu, Emily Kirkpatrick, Amy I Jacobs, Charlotte A Williams, Sunando Roy, Luz M Martin-Bernal, Rachel Williams, Claire Mary Smith, Theo Sanderson, Fiona B Ashford, Beena Emmanuel, Zaheer M Afzal, Adrian M Shields, Alex G Richter, Jienchi Dorward, Oghenekome Gbinigie, Oliver Van Hecke, Mark Lown, Nick Francis, Bhautesh Jani, Duncan B Richards, Najib M Rahman, Ly-Mee Yu, Nicholas P B Thomas, Nigel David Hart, Philip H Evans, Monique I Andersson, Gail Hayward, Kerenza Hood, Jonathan S Nguyen-Van-Tam, Paul Little, F D Richard Hobbs, Saye H Khoo, Christopher C Butler, David M Lowe, Judith Breuer, null null
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature communications 15 (1) (2024)
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A Agyeman, Charles Miller, Mercy Okechukwu, Emily Kirkpatrick, Amy I Jacobs, Charlotte A Williams, Sunando Roy, Luz M Martin-Bernal, Rachel Williams, Claire Mary Smith, Theo Sanderson, Fiona B Ashford, Beena Emmanuel, Zaheer M Afzal, Adrian M Shields, Alex G Richter, Jienchi Dorward, Oghenekome Gbinigie, Oliver Van Hecke, Mark Lown, Nick Francis, Bhautesh Jani, Duncan B Richards, Najib M Rahman, Ly-Mee Yu, Nicholas P B Thomas, Nigel David Hart, Philip H Evans, Monique I Andersson, Gail Hayward, Kerenza Hood, Jonathan S Nguyen-Van-Tam, Paul Little, F D Richard Hobbs, Saye H Khoo, Christopher C Butler, David M Lowe, Judith Breuer, null null
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature communications 15 (1) (2024)
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A Agyeman, Charles Miller, Mercy Okechukwu, Emily Kirkpatrick, Amy I Jacobs, Charlotte A Williams, Sunando Roy, Luz M Martin-Bernal, Rachel Williams, Claire Mary Smith, Theo Sanderson, Fiona B Ashford, Beena Emmanuel, Zaheer M Afzal, Adrian M Shields, Alex G Richter, Jienchi Dorward, Oghenekome Gbinigie, Oliver Van Hecke, Mark Lown, Nick Francis, Bhautesh Jani, Duncan B Richards, Najib M Rahman, Ly-Mee Yu, Nicholas P B Thomas, Nigel David Hart, Philip H Evans, Monique I Andersson, Gail Hayward, Kerenza Hood, Jonathan S Nguyen-Van-Tam, Paul Little, F D Richard Hobbs, Saye H Khoo, Christopher C Butler, David M Lowe, Judith Breuer, null null
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature communications 15 (1) (2024)
Qi Liu, Amita Joshi, Joseph F Standing, Piet H van der Graaf
Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine. Clinical pharmacology and therapeutics 115 (4) (2024)
Suzanne A M Wenker, Najla Alabdulkarim, John B Readman, Elise M A Slob, Giovanni Satta, Shanom Ali, Nishma Gadher, Rob Shulman, Joseph F Standing
Defining the pharmacokinetic/pharmacodynamic index of piperacillin/tazobactam within a hollow-fibre infection model to determine target attainment in intensive care patients. JAC-antimicrobial resistance 6 (2) (2024)
Joseph F Standing, Laura Buggiotti, Jose Afonso Guerra-Assuncao, Maximillian Woodall, Samuel Ellis, Akosua A Agyeman, Charles Miller, Mercy Okechukwu, Emily Kirkpatrick, Amy I Jacobs, Charlotte A Williams, Sunando Roy, Luz M Martin-Bernal, Rachel Williams, Claire Mary Smith, Theo Sanderson, Fiona B Ashford, Beena Emmanuel, Zaheer M Afzal, Adrian M Shields, Alex G Richter, Jienchi Dorward, Oghenekome Gbinigie, Oliver Van Hecke, Mark Lown, Nick Francis, Bhautesh Jani, Duncan B Richards, Najib M Rahman, Ly-Mee Yu, Nicholas P B Thomas, Nigel David Hart, Philip H Evans, Monique I Andersson, Gail Hayward, Kerenza Hood, Jonathan S Nguyen-Van-Tam, Paul Little, F D Richard Hobbs, Saye H Khoo, Christopher C Butler, David M Lowe, Judith Breuer, null null
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. Nature communications 15 (1) (2024)
Joseph F Standing
Could Metabolomics Be the Key to Unlocking Precision Dosing in the Clinic? Clinical pharmacology and therapeutics 113 (2) (2023)
Reya V Shah, Karin Kipper, Emma H Baker, Charlotte I S Barker, Isobel Oldfield, Barbara J Philips, Atholl Johnston, Jeffrey Lipman, Andrew Rhodes, Marina Basarab, Mike Sharland, Sarraa Almahdi, Rachel M Wake, Joseph F Standing, Jeffrey Lipman
Population Pharmacokinetic Study of Benzylpenicillin in Critically Unwell Adults. Antibiotics (Basel, Switzerland) 12 (4) (2023)
D Max Smith, Iris K Minichmayr, Joseph F Standing, Kathleen M Giacomini, Piet H van der Graaf, Richard Wilson Peck
Ensuring Transparency and Quality of Clinical Trial Reporting in Clinical Pharmacology & Therapeutics: Prospective Trial Registration and Compliance with Reporting Guidelines Are Required for all Clinical Trials. Clinical pharmacology and therapeutics 114 (6) (2023)
Joseph F Standing
Could Metabolomics Be the Key to Unlocking Precision Dosing in the Clinic? Clinical pharmacology and therapeutics 113 (2) (2023)
J B Readman, M Acman, A Hamawandi, Cheng-Hsun Chiu, M Sharland, J A Lindsay, Joseph F Standing
Cefotaxime/sulbactam plus gentamicin as a potential carbapenem- and amikacin-sparing first-line combination for neonatal sepsis in high ESBL prevalence settings. The Journal of antimicrobial chemotherapy (2023)
Maddlie Bardol, Shan Pan, Suellen M Walker, Joseph F Standing, Joy M Dawes
Pharmacokinetic pharmacodynamic modeling of analgesics and sedatives in children. Paediatric anaesthesia (2023)
Shengyuan Zhang, Akosua A Agyeman, Christoforos Hadjichrysanthou, Joseph F Standing
SARS-CoV-2 viral dynamic modelling to inform model selection and timing and efficacy of antiviral therapy. CPT: pharmacometrics & systems pharmacology (2023)
Aswin Anand Pai, Ezhilpavai Mohanan, John C Panetta, Uday P Kulkarni, R S Stallon Illangeswaran, Balaji Balakrishnan, Agila Jayaraman, Eunice S Edison, M L Kavitha, Anup J Devasia, N A Fouzia, Anu Korula, Aby Abraham, Biju George, Alok Srivastava, Vikram Mathews, Joseph F Standing, Poonkuzhali Balasubramanian
Treosulfan Exposure Predicts Thalassemia-free Survival In Patients With Beta Thalassemia Major (TM) Undergoing Allogeneic Hematopoietic Cell Transplantation. Clinical pharmacology and therapeutics (2023)
Joseph F Standing
Could Metabolomics Be the Key to Unlocking Precision Dosing in the Clinic? Clinical pharmacology and therapeutics 113 (2) (2023)
Reya V Shah, Karin Kipper, Emma H Baker, Charlotte I S Barker, Isobel Oldfield, Barbara J Philips, Atholl Johnston, Jeffrey Lipman, Andrew Rhodes, Marina Basarab, Mike Sharland, Sarraa Almahdi, Rachel M Wake, Joseph F Standing, Jeffrey Lipman
Population Pharmacokinetic Study of Benzylpenicillin in Critically Unwell Adults. Antibiotics (Basel, Switzerland) 12 (4) (2023)
Charlotte I S Barker, Karin Kipper, Jeffrey Lipman, Kirstie Wright, Georgina Thompson, Min Kim, Mark A Turner, Atholl Johnston, Michael Sharland, Joseph F Standing, null null
The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence. The Journal of antimicrobial chemotherapy (2023)
Akosua A Agyeman, Tao You, Phylinda L S Chan, Jeffrey Lipman, Christoforos Hadjichrysanthou, Tabitha Mahungu, Emmanuel Q Wey, David M Lowe, Marc C I Lipman, Judy Breuer, Frank Kloprogge, Joseph F Standing
Comparative assessment of viral dynamic models for SARS-CoV-2 for pharmacodynamic assessment in early treatment trials. British journal of clinical pharmacology 88 (12) (2022)
Emma Maria Vestesson, John Booth, James Hatcher, Orlagh McGarrity, Neil J Sebire, Adam Steventon, Carlos Suarez Alonso, Stephen Tomlin, Joseph F Standing
The impact of the COVID-19 pandemic on antimicrobial prescribing at a specialist paediatric hospital: an observational study. The Journal of antimicrobial chemotherapy 77 (4) (2022)
Naïm Bouazza, Aristides Dokoumetzidis, Catherijne A J Knibbe, Saskia N de Wildt, Claire Ambery, Pieter A De Cock, Elke Gasthuys, Frantz Foissac, Saïk Urien, Anna-Karin Hamberg, Italo Poggesi, Wei Zhao, An Vermeulen, Joseph F Standing, Jean Marc Treluyer, null null
General clinical and methodological considerations on the extrapolation of pharmacokinetics and optimization of study protocols for small molecules and monoclonal antibodies in children. British journal of clinical pharmacology 88 (12) (2022)
Japhette E Kembou-Ringert, John Readman, Claire M Smith, Judith Breuer, Joseph F Standing
Applications of the hollow-fibre infection model (HFIM) in viral infection studies. The Journal of antimicrobial chemotherapy (2022)
David M Lowe, Li-An K Brown, Kashfia Chowdhury, Stephanie Davey, Philip Yee, Felicia Ikeji, Amalia Ndoutoumou, Divya Shah, Alexander Lennon, Abhulya Rai, Akosua A Agyeman, Anna Checkley, Nicola Longley, Hakim-Moulay Dehbi, Nick Freemantle, Juanita Pang, Joseph F Standing, null null
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19. PLoS medicine 19 (10) (2022)
Joseph F Standing
Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales. The Journal of antimicrobial chemotherapy 77 (7) (2022)
Joseph F Standing
Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants. The Journal of antimicrobial chemotherapy 77 (12) (2022)
James Denzil Morse, Brian Joseph Anderson, Silke Gastine, Ian Chi Kei Ck Wong, Joseph F Standing
Pharmacokinetic modeling and simulation to understand diamorphine dose-response in neonates, children, and adolescents. Paediatric anaesthesia 32 (6) (2022)
Wen Yao Mak, Qing-Xi Ooi, Cintia Valeria Cruz, Irene Looi, Kah Hay Yuen, Joseph F Standing
Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study. British journal of clinical pharmacology (2022)
Silke Gastine, Christina Obiero, Zoe Kane, Phoebe Williams, John Readman, Sheila Murunga, Johnstone Thitiri, Sally Ellis, Erika Correia, Borna Nyaoke, Karin Kipper, John van den Anker, Mike Sharland, James A Berkley, Joseph F Standing
Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis. The Journal of antimicrobial chemotherapy 77 (2) (2022)
Zahra Sadouki, Timothy D McHugh, Rob Aarnoutse, Julio Ortiz Canseco, Christopher Darlow, William Hope, Jakko van Ingen, Christopher Longshaw, Davide Manissero, Andrew Mead, Ludovic Pelligand, Lynette Phee, John Readman, Mike Marvin Ruth, Joseph F Standing, Neil Stone, Emmanuel Q Wey, Frank Kloprogge
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting. The Journal of antimicrobial chemotherapy 76 (9) (2021)
Samuel William Channon-Wells, M Kwok, J Booth, A Bamford, P Konstanty, J Hatcher, G Dixon, P J Diggle, Joseph F Standing, Adam David Irwin
The use of continuous electronic prescribing data to infer trends in antimicrobial consumption and estimate the impact of stewardship interventions in hospitalized children. The Journal of antimicrobial chemotherapy 76 (9) (2021)
Siân Bentley, Jane C Davies, Silke Gastine, Jackie Donovan, Joseph F Standing
Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis. The Journal of antimicrobial chemotherapy 76 (12) (2021)
Anne Smits, Pieter Annaert, Giacomo Cavallaro, Pieter A J G De Cock, Saskia N de Wildt, Jenny M Kindblom, Florian B Lagler, Carmen Moreno, Paula Pokorna, Michiel F Schreuder, Joseph F Standing, Mark A Turner, Benedetto Vitiello, Wei Zhao, Annelie-Martina Weingberg, Raffaella Willmann, John van den Anker, Karel Allegaert
Current knowledge, challenges and innovations in developmental pharmacology: A combined conect4children Expert Group and European Society for Developmental, Perinatal and Paediatric Pharmacology White Paper. British journal of clinical pharmacology (2021)
Zoe Kane, Silke Gastine, Christina Obiero, Phoebe Williams, Sheila Murunga, Johnstone Thitiri, Sally Ellis, Erika Correia, Borna Nyaoke, Karin Kipper, John van den Anker, Mike Sharland, James A Berkley, Joseph F Standing
IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis. The Journal of antimicrobial chemotherapy 76 (7) (2021)
Anna Maria Zylbersztejn, Ofran Almossawi, Nikesh Gudka, Daniel Tompsett, Bianca De Stavola, Joseph F Standing, Rosalind Smyth, Pia Hardelid
Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitals. British journal of clinical pharmacology (2021)
Joseph F Standing
Quantitative Clinical Pharmacology Input to SARS-CoV-2 Therapeutics Should Be Based on Robust Data. Clinical pharmacology and therapeutics 108 (2) (2020)
Maarja Hallik, Mari-Liis Ilmoja, Joseph F Standing, Hiie Soeorg, Tiiu Jalas, Maila Raidmäe, Karin Uibo, Kristel Köbas, Margit Sõnajalg, Kalev Takkis, Rūta Veigure, Karin Kipper, Joel Starkopf, Tuuli Metsvaht
Population pharmacokinetics and pharmacodynamics of dobutamine in neonates on the first days of life. British journal of clinical pharmacology 86 (2) (2020)
Belen P Solans, Robert Chiesa, Bilyana Doncheva, Helen Prunty, Paul Veys, Iñaki F Trocóniz, Joseph F Standing
Modelling of neutrophil dynamics in children receiving busulfan or treosulfan for haematopoietic stem cell transplant conditioning. British journal of clinical pharmacology 86 (8) (2020)
Sonja Eberl, Gabriele Ahne, Irmgard Toni, Joseph F Standing, Antje Neubert
Safety of clonidine used for long-term sedation in paediatric intensive care: A systematic review. British journal of clinical pharmacology 87 (3) (2020)
Sophida Boonsathorn, Iek Cheng, Frank Kloprogge, Carlos Alonso, Charmion Lee, Bilyana Doncheva, John Booth, Robert Chiesa, Adam Irwin, Joseph F Standing
Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children. Clinical pharmacokinetics 58 (1) (2020)
Shan Pan, Huixin Yu, Ayesha Surti, Iek Cheng, Stephen D Marks, Paul A Brogan, Despina Eleftheriou, Joseph F Standing
Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases. British journal of clinical pharmacology 85 (8) (2019)
Jeffrey Lipman, Emma H Baker, Karin Kipper, Charlotte I S Barker, Barbara Philips, Andrew Rhodes, Mike Sharland, Joseph F Standing
Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age. British journal of clinical pharmacology 85 (2) (2018)